Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

C-reactive protein as a diagnostic tool in differential diagnosis of hypereosinophilic syndrome and ANCA-negative eosinophilic granulomatosis with polyangiitis.

Leurs A, Chenivesse C, Lopez B, Gibier JB, Clément G, Groh M, Copin MC, Staumont D, Mortuaire G, Balquet MH, Dezoteux F, Bautin N, Buchdahl AL, Le Gouellec N, Etienne N, Terriou L, Dubucquoi S, Labalette M, Morell-Dubois S, Maillard-Lefebvre H, Lambert M, Hachulla E, Launay D, Kahn JE, Hatron PY, Lefèvre G.

J Allergy Clin Immunol Pract. 2018 Oct 11. pii: S2213-2198(18)30659-7. doi: 10.1016/j.jaip.2018.10.002. [Epub ahead of print] No abstract available.

PMID:
30317003
2.

HLA-DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation.

Ducreux S, Dubois V, Amokrane K, Yakoub-Agha I, Labalette M, Michallet M, Rubio MT, Kennel A, Forcade E, Lafarge X, Bulabois CE, Masson D, Daguindau E, Devys A, Moalic V, Quelvennec E, Boudifa A, Picard C, Van Endert P, de Matteis M, Delbos F, Filloux M, Pedron B, Renac V, Hau F, Bonneau J, Parissiadis A, Fort M, Dormoy A, Maillard N, Jollet I, Chevallier P, Cesbron A, Bay JO, Quainon F, Garnier F, Socié G, Loiseau P, Porcher R, Peffault de Latour R; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI).

Am J Hematol. 2018 May 4. doi: 10.1002/ajh.25133. [Epub ahead of print]

PMID:
29726580
3.

Immunoglobulin G (IgG) and IgG subclass reference intervals in children, using Optilite® reagents.

Grunewald O, Lopez B, Brabant S, Rogeau S, Deschildre A, Phrommavanh V, Lefort M, Moitrot E, Gyselinckx D, Deleplancque AS, Lefevre G, Labalette M, Dubucquoi S.

Clin Chem Lab Med. 2018 Jul 26;56(8):1319-1327. doi: 10.1515/cclm-2018-0001.

PMID:
29630506
4.

Reply to Gilchrist et al. and to Musher.

Lopez B, Boucher A, Bahuaud M, Mortuaire G, Melliez H, Launay D, Terriou L, Wemeau-Stervinou L, Wallaert B, Faure K, Wallet F, Hachulla E, Hatron PY, Dubucquoi S, Batteux F, Labalette M, Lefèvre G.

Clin Infect Dis. 2018 Feb 1;66(4):637-638. doi: 10.1093/cid/cix866. No abstract available.

PMID:
29401278
5.

Altered B lymphocyte homeostasis and functions in systemic sclerosis.

Forestier A, Guerrier T, Jouvray M, Giovannelli J, Lefèvre G, Sobanski V, Hauspie C, Hachulla E, Hatron PY, Zéphir H, Vermersch P, Labalette M, Launay D, Dubucquoi S.

Autoimmun Rev. 2018 Mar;17(3):244-255. doi: 10.1016/j.autrev.2017.10.015. Epub 2018 Jan 16. Review.

PMID:
29343447
6.

Value of the Overall Pneumococcal Polysaccharide Response in the Diagnosis of Primary Humoral Immunodeficiencies.

Lopez B, Bahuaud M, Fieschi C, Mehlal S, Jeljeli M, Rogeau S, Brabant S, Deleplancque AS, Dubucquoi S, Poizot S, Terriou L, Launay D, Batteux F, Labalette M, Lefèvre G.

Front Immunol. 2017 Dec 20;8:1862. doi: 10.3389/fimmu.2017.01862. eCollection 2017.

7.

A standardized flow cytometry procedure for the monitoring of regulatory T cells in clinical trials.

Pitoiset F, Barbié M, Monneret G, Braudeau C, Pochard P, Pellegrin I, Trauet J, Labalette M, Klatzmann D, Rosenzwajg M.

Cytometry B Clin Cytom. 2018 Sep;94(5):621-626. doi: 10.1002/cyto.b.21622. Epub 2018 Jan 23.

PMID:
29316248
8.

Proinflammatory B-cell profile in the early phases of MS predicts an active disease.

Guerrier T, Labalette M, Launay D, Lee-Chang C, Outteryck O, Lefèvre G, Vermersch P, Dubucquoi S, Zéphir H.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 22;5(2):e431. doi: 10.1212/NXI.0000000000000431. eCollection 2018 Mar.

9.

[Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Yakoub-Agha I, Ferrand C, Chalandon Y, Ballot C, Castilla Llorente C, Deschamps M, Gauthier J, Labalette M, Larghero J, Maheux C, Moreau AS, Varlet P, Pétillon MO, Pinturaud M, Rubio MT, Chabannon C.

Bull Cancer. 2017 Dec;104(12S):S43-S58. doi: 10.1016/j.bulcan.2017.10.017. Epub 2017 Nov 23. French.

PMID:
29174320
10.

Specific Polysaccharide Antibody Deficiency Revealed by Severe Bacterial Infections in Adulthood: A Report on 11 Cases.

Lopez B, Boucher A, Bahuaud M, Mortuaire G, Melliez H, Launay D, Terriou L, Wemeau-Stervinou L, Wallaert B, Faure K, Wallet F, Hachulla E, Hatron PY, Dubucquoi S, Batteux F, Labalette M, Lefèvre G.

Clin Infect Dis. 2017 Jul 15;65(2):328-331. doi: 10.1093/cid/cix284.

PMID:
28379361
11.

An avoidable cause of thymoglobulin anaphylaxis.

Brabant S, Facon A, Provôt F, Labalette M, Wallaert B, Chenivesse C.

Allergy Asthma Clin Immunol. 2017 Feb 23;13:13. doi: 10.1186/s13223-017-0186-9. eCollection 2017.

12.

B Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis.

Sanges S, Jendoubi M, Kavian N, Hauspie C, Speca S, Crave JC, Guerrier T, Lefèvre G, Sobanski V, Savina A, Hachulla E, Hatron PY, Labalette M, Batteux F, Dubucquoi S, Launay D.

Front Immunol. 2017 Feb 7;8:53. doi: 10.3389/fimmu.2017.00053. eCollection 2017.

13.

Diagnosis of primary antibody and complement deficiencies in young adults after a first invasive bacterial infection.

Sanges S, Wallet F, Blondiaux N, Theis D, Vérin I, Vachée A, Dessein R, Faure K, Viget N, Senneville E, Leroy O, Maury F, Just N, Poissy J, Mathieu D, Prévotat A, Chenivesse C, Scherpereel A, Smith G, Lopez B, Rosain J, Frémeaux-Bacchi V, Hachulla E, Hatron PY, Bahuaud M, Batteux F, Launay D, Labalette M, Lefèvre G.

Clin Microbiol Infect. 2017 Aug;23(8):576.e1-576.e5. doi: 10.1016/j.cmi.2017.02.005. Epub 2017 Feb 10.

14.

Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.

Carapito R, Jung N, Kwemou M, Untrau M, Michel S, Pichot A, Giacometti G, Macquin C, Ilias W, Morlon A, Kotova I, Apostolova P, Schmitt-Graeff A, Cesbron A, Gagne K, Oudshoorn M, van der Holt B, Labalette M, Spierings E, Picard C, Loiseau P, Tamouza R, Toubert A, Parissiadis A, Dubois V, Lafarge X, Maumy-Bertrand M, Bertrand F, Vago L, Ciceri F, Paillard C, Querol S, Sierra J, Fleischhauer K, Nagler A, Labopin M, Inoko H, von dem Borne PA, Kuball J, Ota M, Katsuyama Y, Michallet M, Lioure B, Peffault de Latour R, Blaise D, Cornelissen JJ, Yakoub-Agha I, Claas F, Moreau P, Milpied N, Charron D, Mohty M, Zeiser R, Socié G, Bahram S.

Blood. 2016 Oct 13;128(15):1979-1986. Epub 2016 Aug 22.

15.

Role of B cells in the pathogenesis of systemic sclerosis.

Sanges S, Guerrier T, Launay D, Lefèvre G, Labalette M, Forestier A, Sobanski V, Corli J, Hauspie C, Jendoubi M, Yakoub-Agha I, Hatron PY, Hachulla E, Dubucquoi S.

Rev Med Interne. 2017 Feb;38(2):113-124. doi: 10.1016/j.revmed.2016.02.016. Epub 2016 Mar 25. Review.

PMID:
27020403
16.

Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI.

Cluzeau T, Lambert J, Raus N, Dessaux K, Absi L, Delbos F, Devys A, De Matteis M, Dubois V, Filloux M, Fort M, Hau F, Jollet I, Labalette M, Masson D, Mercier B, Pedron B, Perrier P, Picard C, Quainon F, Ramounau-Pigot A, Renac V, Van Endert P, Charron D, Peffault de la Tour R, Taupin JL, Loiseau P.

Bone Marrow Transplant. 2016 May;51(5):687-91. doi: 10.1038/bmt.2015.351. Epub 2016 Feb 8.

PMID:
26855158
17.

Suggestive evidence of a role of HLA-DRB4 mismatches in the outcome of allogeneic hematopoietic stem cell transplantation with HLA-10/10-matched unrelated donors: a French-Swiss retrospective study.

Detrait M, Morisset S, Chalandon Y, Yakoub-Agha I, Dufossé F, Labalette M, Top I, Elsermans V, Barraco F, Quintela A, Tedone N, Michallet M, Raus N, Tiercy JM, Dubois V.

Bone Marrow Transplant. 2015 Oct;50(10):1316-20. doi: 10.1038/bmt.2015.157. Epub 2015 Jul 6.

PMID:
26146803
18.

Donor caveolin 1 (CAV1) genetic polymorphism influences graft function after renal transplantation.

Van der Hauwaert C, Savary G, Pinçon C, Gnemmi V, Noël C, Broly F, Labalette M, Perrais M, Pottier N, Glowacki F, Cauffiez C.

Fibrogenesis Tissue Repair. 2015 May 5;8:8. doi: 10.1186/s13069-015-0025-x. eCollection 2015.

19.

CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder.

Lefèvre G, Copin MC, Roumier C, Aubert H, Avenel-Audran M, Grardel N, Poulain S, Staumont-Sallé D, Seneschal J, Salles G, Ghomari K, Terriou L, Leclech C, Morati-Hafsaoui C, Morschhauser F, Lambotte O, Ackerman F, Trauet J, Geffroy S, Dumezy F, Capron M, Roche-Lestienne C, Taieb A, Hatron PY, Dubucquoi S, Hachulla E, Prin L, Labalette M, Launay D, Preudhomme C, Kahn JE; French Eosinophil Network.

Haematologica. 2015 Aug;100(8):1086-95. doi: 10.3324/haematol.2014.118042. Epub 2015 Feb 14.

20.

A low effective dose of interleukin-7 is sufficient to maintain cord blood T cells alive without potentiating allo-immune responses.

Pascal L, Hivert B, Trauet J, Deberranger E, Dessaint JP, Yakoub-Agha I, Labalette M.

Biol Blood Marrow Transplant. 2015 Apr;21(4):625-31. doi: 10.1016/j.bbmt.2014.11.678. Epub 2015 Jan 30.

21.

The novel HLA-B*39:93 allele was identified by sequence-based typing in a French family.

Elsermans V, Top I, Farchi O, Varlet P, Labalette M.

Tissue Antigens. 2015 Feb;85(2):144-5. doi: 10.1111/tan.12508.

PMID:
25626610
22.

B-cell subpopulations in children: National reference values.

Duchamp M, Sterlin D, Diabate A, Uring-Lambert B, Guérin-El Khourouj V, Le Mauff B, Monnier D, Malcus C, Labalette M, Picard C.

Immun Inflamm Dis. 2014 Nov;2(3):131-40. doi: 10.1002/iid3.26. Epub 2014 Jul 31.

23.

The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype.

Lefèvre G, Copin MC, Staumont-Sallé D, Avenel-Audran M, Aubert H, Taieb A, Salles G, Maisonneuve H, Ghomari K, Ackerman F, Legrand F, Baruchel A, Launay D, Terriou L, Leclech C, Khouatra C, Morati-Hafsaoui C, Labalette M, Borie R, Cotton F, Gouellec NL, Morschhauser F, Trauet J, Roche-Lestienne C, Capron M, Hatron PY, Prin L, Kahn JE; French Eosinophil Network.

Medicine (Baltimore). 2014 Oct;93(17):255-66. doi: 10.1097/MD.0000000000000088.

24.

Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies.

Pascal L, Mohty M, Ruggeri A, Tucunduva L, Milpied N, Chevallier P, Tabrizi R, Labalette M, Gluckman E, Labopin M, Yakoub-Agha I.

Bone Marrow Transplant. 2015 Jan;50(1):45-50. doi: 10.1038/bmt.2014.216. Epub 2014 Oct 20.

PMID:
25330221
25.

[The impact of donor naive and memory T cell subsets on patient outcome following allogeneic stem cell transplantation: relationship between infused donor CD4+/CCR7+ T cell subsets and acute graft-versus-host disease].

Choufi B, Thiant S, Trauet J, Cliquennois M, Cherrel M, Boulanger F, Coiteux V, Magro L, Labalette M, Yakoub-Agha I.

Pathol Biol (Paris). 2014 Jun;62(3):123-8. doi: 10.1016/j.patbio.2014.02.013. Epub 2014 Jun 3. French.

PMID:
24906571
26.

Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice.

Makki K, Taront S, Molendi-Coste O, Bouchaert E, Neve B, Eury E, Lobbens S, Labalette M, Duez H, Staels B, Dombrowicz D, Froguel P, Wolowczuk I.

PLoS One. 2014 Apr 7;9(4):e92684. doi: 10.1371/journal.pone.0092684. eCollection 2014.

27.

Donor-derived CD4(+)/CCR7(+) T-cell partial selective depletion does not alter acquired anti-infective immunity.

Choufi B, Trauet J, Thiant S, Labalette M, Yakoub-Agha I.

Bone Marrow Transplant. 2014 May;49(5):611-5. doi: 10.1038/bmt.2014.6. Epub 2014 Feb 24.

PMID:
24566708
28.

Naïve subset develops the most important alloreactive response among human CD4+ T lymphocytes in human leukocyte antigen-identical related setting.

Chérel M, Choufi B, Trauet J, Cracco P, Dessaint JP, Yakoub-Agha I, Labalette M.

Eur J Haematol. 2014 Jun;92(6):491-6. doi: 10.1111/ejh.12283. Epub 2014 Mar 15.

PMID:
24520815
29.

Novel HLA-C*07:314 allele identified by sequence-based typing in a French lymphoblastic leukemia patient.

Elsermans V, Top I, Kuzio EM, Ballieu S, Labalette M.

Tissue Antigens. 2013 Dec;82(6):439-40. doi: 10.1111/tan.12208. Epub 2013 Oct 16. No abstract available.

PMID:
24131084
30.

Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.

Scherpereel A, Grigoriu BD, Noppen M, Gey T, Chahine B, Baldacci S, Trauet J, Copin MC, Dessaint JP, Porte H, Labalette M.

BMC Cancer. 2013 Jul 2;13:324. doi: 10.1186/1471-2407-13-324.

31.

Effect of in vitro and in vivo anakinra on cytokines production in Schnitzler syndrome.

Launay D, Dutoit-Lefevre V, Faure E, Robineau O, Hauspie C, Sobanski V, Hachulla E, Labalette M, Hatron PY, Dubucquoi S.

PLoS One. 2013;8(3):e59327. doi: 10.1371/journal.pone.0059327. Epub 2013 Mar 19.

32.

[Attempted suicide by intrapulmonary self-injection of White spirit®].

Godard A, Labalette M, Lenot B, Lepitre N.

Ann Fr Anesth Reanim. 2012 Dec;31(12):975-7. doi: 10.1016/j.annfar.2012.10.010. Epub 2012 Nov 16. French. No abstract available.

PMID:
23159516
33.

Diagnostic value of single complete compression ultrasonography in pregnant and postpartum women with suspected deep vein thrombosis: prospective study.

Le Gal G, Kercret G, Ben Yahmed K, Bressollette L, Robert-Ebadi H, Riberdy L, Louis P, Delluc A, Labalette ML, Baba-Ahmed M, Bounameaux H, Mottier D, Righini M; EDVIGE Study Group.

BMJ. 2012 Apr 24;344:e2635. doi: 10.1136/bmj.e2635.

34.

Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patients.

Buob D, Grimbert P, Glowacki F, Labalette M, Dufossé F, Nochy D, Copin MC, Boleslawski E, Noël C, Hazzan M.

Transpl Int. 2012 Jun;25(6):663-70. doi: 10.1111/j.1432-2277.2012.01473.x. Epub 2012 Apr 5.

35.

Posttransplant major histocompatibility complex class I chain-related gene A antibodies and long-term graft outcomes in a multicenter cohort of 779 kidney transplant recipients.

Lemy A, Andrien M, Lionet A, Labalette M, Noel C, Hiesse C, Delahousse M, Suberbielle-Boissel C, De Meyer M, Latinne D, Mourad M, Delsaut S, Racapé J, Wissing KM, Toungouz M, Abramowicz D.

Transplantation. 2012 Jun 27;93(12):1258-64. doi: 10.1097/TP.0b013e31824fd8f1.

PMID:
22466790
36.

CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation.

Glowacki F, Lionet A, Buob D, Labalette M, Allorge D, Provôt F, Hazzan M, Noël C, Broly F, Cauffiez C.

Nephrol Dial Transplant. 2011 Sep;26(9):3046-50. doi: 10.1093/ndt/gfr253. Epub 2011 Jun 15.

PMID:
21677300
37.

Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on the pharmacokinetics of the prolonged-release, once-daily formulation of tacrolimus in stable renal transplant recipients.

Glowacki F, Lionet A, Hammelin JP, Labalette M, Provôt F, Hazzan M, Broly F, Noël C, Cauffiez C.

Clin Pharmacokinet. 2011 Jul;50(7):451-9. doi: 10.2165/11587050-000000000-00000.

PMID:
21528942
38.

Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.

Saint-Marcoux F, Debord J, Parant F, Labalette M, Kamar N, Rostaing L, Rousseau A, Marquet P.

Ther Drug Monit. 2011 Apr;33(2):171-7. doi: 10.1097/FTD.0b013e31820d6ef7.

PMID:
21383655
39.

Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD.

Thiant S, Labalette M, Trauet J, Coiteux V, de Berranger E, Dessaint JP, Yakoub-Agha I.

Bone Marrow Transplant. 2011 Oct;46(10):1374-81. doi: 10.1038/bmt.2010.300. Epub 2010 Dec 6.

PMID:
21132028
40.

Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse.

Thiant S, Yakoub-Agha I, Magro L, Trauet J, Coiteux V, Jouet JP, Dessaint JP, Labalette M.

Bone Marrow Transplant. 2010 Oct;45(10):1546-52. doi: 10.1038/bmt.2010.13. Epub 2010 Mar 1.

PMID:
20190846
41.

Long-term kinetics of a T-lymphocytes subset in kidney transplant recipients: relationship with posttransplant malignancies.

Glowacki F, Al Morabiti M, Lionet A, Labalette M, Provot F, Noel C, Hazzan M.

Transplant Proc. 2009 Oct;41(8):3323-5. doi: 10.1016/j.transproceed.2009.09.033.

PMID:
19857742
42.

Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse.

Yakoub-Agha I, Saule P, Magro L, Cracco P, Duhamel A, Coiteux V, Bruno B, Dufossé F, Jouet JP, Dessaint JP, Labalette M.

Biol Blood Marrow Transplant. 2009 Apr;15(4):496-504. doi: 10.1016/j.bbmt.2008.11.038. Epub 2009 Feb 12.

43.

Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.

Wallemacq P, Goffinet JS, O'Morchoe S, Rosiere T, Maine GT, Labalette M, Aimo G, Dickson D, Schmidt E, Schwinzer R, Schmid RW.

Ther Drug Monit. 2009 Apr;31(2):198-204. doi: 10.1097/FTD.0b013e31819c6a37.

PMID:
19258928
44.

Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice.

Mineo JF, Scheffer A, Karkoutly C, Nouvel L, Kerdraon O, Trauet J, Bordron A, Dessaint JP, Labalette M, Berthou C, Labalette P.

Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4738-45. doi: 10.1167/iovs.07-1494. Epub 2008 Jun 14.

PMID:
18552383
45.

Cytokine concentrations in exhaled breath condensates in systemic sclerosis.

Edmé JL, Tellart AS, Launay D, Neviere R, Grutzmacher C, Boulenguez C, Labalette M, Hachulla E, Hatron PY, Dessaint JP, Matran R, Sobaszek A.

Inflamm Res. 2008 Apr;57(4):151-6. doi: 10.1007/s00011-007-7136-9.

PMID:
18351434
46.

Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics.

Yakoub-Agha I, Saule P, Depil S, Grutzmacher C, Boulanger F, Magro L, Jouet JP, Dessaint JP, Labalette M.

Exp Hematol. 2007 Jun;35(6):861-71.

PMID:
17533040
47.

Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma.

Plonquet A, Haioun C, Jais JP, Debard AL, Salles G, Bene MC, Feugier P, Rabian C, Casasnovas O, Labalette M, Kuhlein E, Farcet JP, Emile JF, Gisselbrecht C, Delfau-Larue MH; Groupe d'étude des lymphomes de l'adulte.

Ann Oncol. 2007 Jul;18(7):1209-15. Epub 2007 May 12.

PMID:
17496307
48.

Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease.

Krystkowiak P, Gaura V, Labalette M, Rialland A, Remy P, Peschanski M, Bachoud-Lévi AC.

PLoS One. 2007 Jan 24;2(1):e166.

49.

Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial.

Hazzan M, Buob D, Labalette M, Provot F, Glowacki F, Hoffmann M, Copin MC, Noel C.

Transplantation. 2006 Sep 15;82(5):657-62.

PMID:
16969289
50.

A high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy.

Yakoub-Agha I, Saule P, Depil S, Micol JB, Grutzmacher C, Boulanger-Villard F, Bauters F, Jouet JP, Dessaint JP, Labalette M.

Leukemia. 2006 Sep;20(9):1557-65. Epub 2006 Jul 6.

PMID:
16826221

Supplemental Content

Loading ...
Support Center